Faeth Therapeutics, Inc. (FTH) stock
FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.03−0.62 (-5.82%)
Close on Nov 13, 2026Market cap $259.18MP/E –Yield –
Faeth Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Faeth Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$33.86M. For fiscal 2025 it was -$20.45M. The highest annual figure on record is -$17.71M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$20.45M | – |
| FY2024 | Dec 31, 2024 | -$24.67M | – |
| FY2023 | Dec 31, 2023 | -$32.02M | – |
| FY2022 | Dec 31, 2022 | -$39.03M | – |
| FY2021 | Dec 31, 2021 | -$30.26M | – |
| FY2020 | Dec 31, 2020 | -$17.71M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.67M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.73M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.86M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.59M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.91M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.09M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.79M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.47M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.79M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.62M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.16M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.66M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.46M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.74M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.57M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.80M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.90M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.75M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.87M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.05M | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.77M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.68M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.80M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.77M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.46M | – |
See a number that looks wrong?